6876 - 6900 of 7939 Results
Title
Year
-
RESTRICTEDTitle: Striatal cholinergic interneuron regulation and circuit effectsJournal Name: Frontiers in Synaptic NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnsyn.2014.00022Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnsyn.2014.00022/pdfCitation Count: 176
-
OPENTitle: Mind matters: placebo enhances reward learning in Parkinson's diseaseJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 17Issue #: 12Start Page: 1793End Page: 1797Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.3842Best OA location URL: https://europepmc.org/articles/pmc4503317?pdf=renderCitation Count: 78
- New ghrelin agonist, HM01 alleviates constipation and L‐dopa‐delayed gastric emptying in 6‐hydroxydopamine rat model of Parkinson's disease2014OPENTitle: New ghrelin agonist, HM01 alleviates constipation and L‐dopa‐delayed gastric emptying in 6‐hydroxydopamine rat model of Parkinson's diseaseJournal Name: Neurogastroenterology & MotilityPublisher: WileyVol: 26Issue #: 12Start Page: 1771End Page: 1782Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/nmo.12459Best OA location URL: https://europepmc.org/articles/pmc4457321?pdf=renderCitation Count: 49
- α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)2014RESTRICTEDTitle: α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)Journal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 73Issue #:Start Page: 229End Page: 243Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.007Citation Count: 34
-
OPENTitle: Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 10Start Page: e108982End Page: e108982Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0108982Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0108982&type=printableCitation Count: 76
- Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease2014OPENTitle: Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 1394End Page: 1398Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.10.008Best OA location URL: https://europepmc.org/articles/pmc4314515?pdf=renderCitation Count: 84
-
OPENTitle: Sensitive measures of executive dysfunction in non-demented Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 1430End Page: 1433Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.10.007Best OA location URL: https://escholarship.org/content/qt32g6f0vn/qt32g6f0vn.pdf?t=rt4g05Citation Count: 15
- Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis2014OPENTitle: Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosisJournal Name: European Journal of NeurologyPublisher: WileyVol: 22Issue #: 2Start Page: 328End Page: 333Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.12572Best OA location URL: https://europepmc.org/articles/pmc4289423?pdf=renderCitation Count: 46
- Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome2014OPENTitle: Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteomeJournal Name: PROTEOMICSPublisher: WileyVol: 15Issue #: 2-3Start Page: 500End Page: 507Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pmic.201400171Best OA location URL: https://europepmc.org/articles/pmc4598062?pdf=renderCitation Count: 48
-
RESTRICTEDTitle: What matters to people with Parkinson’s disease living in Australia?Journal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 22Issue #: 2Start Page: 338End Page: 341Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2014.06.097Citation Count: 9
-
OPENTitle: Imaging prodromal Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 83Issue #: 19Start Page: 1739End Page: 1746Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000000960Best OA location URL: https://europepmc.org/articles/pmc4239830?pdf=renderCitation Count: 145
- Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer’s disease brains and human microglia2014OPENTitle: Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer’s disease brains and human microgliaJournal Name: NeurosciencePublisher: Elsevier BVVol: 302Issue #:Start Page: 121End Page: 137Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.09.052Best OA location URL: https://europepmc.org/articles/pmc4385752?pdf=renderCitation Count: 48
-
OPENTitle: Treatment of myoclonus-dystonia syndrome with tetrabenazineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 1423End Page: 1426Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.09.029Best OA location URL: https://europepmc.org/articles/pmc4254189?pdf=renderCitation Count: 31
- AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo2014RESTRICTEDTitle: AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivoJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 73Issue #:Start Page: 150End Page: 162Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.09.013Citation Count: 62
- Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex2014OPENTitle: Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortexJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 571End Page: 582Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.09.023Best OA location URL: https://europepmc.org/articles/pmc4315751?pdf=renderCitation Count: 80
- Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis2014OPENTitle: Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axisJournal Name: American Journal of Physiology-Gastrointestinal and Liver PhysiologyPublisher: American Physiological SocietyVol: 307Issue #: 10Start Page: G1013End Page: G1023Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/ajpgi.00258.2014Best OA location URL: https://europepmc.org/articles/pmc4865236Citation Count: 47
-
OPENTitle: Network Analysis Identifies SOD2 mRNA as a Potential Biomarker for Parkinson's DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 10Start Page: e109042End Page: e109042Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0109042Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0109042&type=printableCitation Count: 30
-
OPENTitle: Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson’s diseaseJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 9Issue #: 3Start Page: 619End Page: 638Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11682-014-9317-9Best OA location URL: https://europepmc.org/articles/pmc4385510?pdf=renderCitation Count: 31
-
OPENTitle: Highlights of the Stockholm Congress: A Clinician's PerspectiveJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 4Start Page: 277End Page: 279Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12093Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12093Citation Count: 0
-
RESTRICTEDTitle: Novel insights into the neurobiology underlying LRRK2-linked Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 85Issue #:Start Page: 45End Page: 56Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2014.05.020Citation Count: 21
-
RESTRICTEDTitle: The Nuclear Envelope: An Intriguing Focal Point for Neurogenetic DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 764End Page: 772Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-014-0296-8Best OA location URL: https://europepmc.org/articles/pmc4391386?pdf=renderCitation Count: 17
- Hybrid Bayesian-rank integration approach improves the predictive power of genomic dataset aggregation2014OPENTitle: Hybrid Bayesian-rank integration approach improves the predictive power of genomic dataset aggregationJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 31Issue #: 2Start Page: 209End Page: 215Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/bioinformatics/btu518Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/31/2/209/17125420/btu518.pdfCitation Count: 17
- Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases2014OPENTitle: Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseasesJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 111Issue #: 41Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1405003111Best OA location URL: https://www.pnas.org/content/pnas/111/41/E4367.full.pdfCitation Count: 529
-
RESTRICTEDTitle: The Role of microRNAs in Mitochondria: Small Players Acting WideJournal Name: GenesPublisher: MDPI AGVol: 5Issue #: 4Start Page: 865End Page: 886Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes5040865Best OA location URL: https://www.mdpi.com/2073-4425/5/4/865/pdf?version=1411736411Citation Count: 116
- Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers2014OPENTitle: Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriersJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2014.00248Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2014.00248/pdfCitation Count: 62